RxDoctor Payments Data

Tyler Tewilliager, DPM

Podiatrist · Houma, LANPI 1295230118

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,761 of the $15,900 with a category attached, or 61.4%. It is spread thinly across 35 manufacturers, the largest accounting for just 19.2%. Among podiatrist clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,900in general payments, 2019–2025

Across 150 payments — averaging $106.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Vilex LLC$2K
  • Medline Industries LP$2K
  • Gemini Mountain Medical, LLC$1K
  • Restor3d, Inc.$1K
  • Paragon 28, Inc.$857
  • plus $5K from 29 others

What the payments were for

  • Travel & lodging$4,89431%
  • Food & beverage$9,76161%
  • Education$1,2008%
  • Gifts$460%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,900 in reported general payments places this provider in the 95th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$52,624
Medicare patients
111
Services billed
451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox16$205

Paid to pharmacies, not to this prescriber.

Other podiatrist in Houma

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →